Acquired Blepharoptosis clinical trials

Explore recruiting acquired blepharoptosis clinical trials.

Recruiting acquired blepharoptosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acquired Blepharoptosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID) in the Treatment of Acquired Blepharoptosis

Hungary, Germany, Spain, Italy, France, Czechia +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acquired Blepharoptosis trials by city

Acquired Blepharoptosis in Toronto Acquired Blepharoptosis in Vancouver Acquired Blepharoptosis in Montreal Acquired Blepharoptosis in Calgary Acquired Blepharoptosis in Edmonton Acquired Blepharoptosis in Ottawa Acquired Blepharoptosis in Winnipeg Acquired Blepharoptosis in Quebec City Acquired Blepharoptosis in Hamilton Acquired Blepharoptosis in Kitchener Acquired Blepharoptosis in London Acquired Blepharoptosis in Halifax Acquired Blepharoptosis in New York Acquired Blepharoptosis in Los Angeles Acquired Blepharoptosis in Chicago Acquired Blepharoptosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease